Halozyme Therapeutics (HALO) Return on Invested Capital [ROIC] (2016 - 2026)
Halozyme Therapeutics (HALO) posted Return on Invested Capital [ROIC] of 18.19% for Q2 2026, down 10.50 percentage points from 28.69% a year earlier but up 2.62 percentage points from the prior quarter.
Powered by 
Analysis
Halozyme Therapeutics (HALO) Return on Invested Capital [ROIC] (2016 - 2026) Analysis & Trends
For FY2025, Halozyme Therapeutics' Return on Invested Capital [ROIC] came in at 15.68%, down 9.79 percentage points from FY2024.
- Annual Return on Invested Capital [ROIC] shows a five-year change of -27.99 percentage points (FY2020 to FY2025).
- In prior years, Halozyme Therapeutics' Return on Invested Capital [ROIC] was 25.46% in FY2024 (+8.72 pp), 16.75% in FY2023 (+0.95 pp), 15.80% in FY2022 (-18.22 pp) and 34.02% in FY2021 (-9.65 pp).
- Quarterly Return on Invested Capital [ROIC] has run from a low of 12.16% in Q1 2023 to a high of 102.44% in Q3 2021 over five years.
- On a year-over-year basis, Return on Invested Capital [ROIC] has declined in each of the last three quarters, with an average year-over-year change of +1.34 percentage points over the last eight quarters.
- The strongest year-over-year quarter for Return on Invested Capital [ROIC] in the past five years was Q3 2021, with a gain of 68.75 percentage points; the weakest was Q3 2022, with a drop of 79.74 percentage points.
- According to Business Quant data, Return on Invested Capital [ROIC] for the three prior quarters was 15.58% (Q1 2026), 15.14% (Q4 2025) and 30.53% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 37.16% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 16.10% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 18.68% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 3.56% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 21.95% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 28.83% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 14.33% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 13.44% |
| 10 | Halozyme Therapeutics | 12.53 Bn | 11.13 Bn | 401.83 Mn | 18.19% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 18.19% |
| Mar 31, 2026 | 15.58% |
| Dec 31, 2025 | 15.14% |
| Sep 30, 2025 | 30.53% |
| Jun 30, 2025 | 28.69% |
| Mar 31, 2025 | 24.84% |
| Dec 31, 2024 | 22.98% |
| Sep 30, 2024 | 20.80% |
| Jun 30, 2024 | 18.76% |
| Mar 31, 2024 | 18.91% |
| Dec 31, 2023 | 16.39% |
| Sep 30, 2023 | 14.64% |
| Jun 30, 2023 | 15.39% |
| Mar 31, 2023 | 12.16% |
| Dec 31, 2022 | 13.26% |
| Sep 30, 2022 | 22.70% |
| Jun 30, 2022 | 65.19% |
| Mar 31, 2022 | 42.27% |
| Dec 31, 2021 | 38.20% |
| Sep 30, 2021 | 102.44% |
API Access
Halozyme Therapeutics Return on Invested Capital [ROIC] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=HALO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-invested-capital-[roic]", "ticker": "HALO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=HALO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();